This guide provides a transparent, data-backed comparison of procedure costs across four countries, sourced from WHO Health Statistics, OECD Health Data 2024, and published hospital pricing from Grade 3A institutions in Beijing and Shanghai.
Medical tourism to China has grown significantly as patients seek high-quality care at substantially lower cost. Grade 3A hospitals in China meet or exceed international accreditation standards for most elective procedures.
Why China for Medical Tourism?
China’s Grade 3A hospital network — approximately 1,500 institutions out of 35,000+ nationwide — represents the country’s highest tier of clinical excellence. According to the OECD Health Statistics 2024, China’s top-tier hospitals report surgical complication rates comparable to leading Western institutions for elective procedures including orthopedic surgery, ophthalmology, and dental implantology.
Key cost drivers that make China affordable:
- Lower labour costs relative to Western markets (OECD data)
- Government-subsidised hospital infrastructure
- High procedure volume enabling economies of scale
- No medical liability insurance premiums embedded in pricing
Savings at a Glance
A quick five-procedure summary across China, USA, UK, and Australia, with typical savings for each.
| Procedure | China | USA | UK | Australia | Typical savings |
|---|---|---|---|---|---|
| Executive health screening | from $500 | $2,000 | $1,500 | $1,800 | 60–70% |
| Dental implant (single) | $800–$1,500 | $3,000–$5,000 | $2,500–$3,500 | $4,000–$5,000 | 65–80% |
| LASIK (both eyes) | from $1,500 | $4,000–$5,000 | $4,000 | $5,000 | 50–60% |
| Hip replacement | $8,000–$15,000 | $30,000–$50,000 | $25,000–$35,000 | $25,000–$35,000 | 50–70% |
| Knee replacement | $7,500–$14,000 | $35,000–$50,000 | $26,000–$35,000 | $28,000–$38,000 | 50–70% |
Procedure Cost Comparison Table
All prices are in USD. China prices reflect Grade 3A hospital rates in Beijing or Shanghai, inclusive of the procedure and standard follow-up. Western prices are median market rates sourced from published insurer data and government health statistics.
| Procedure | China (Grade 3A) | USA | UK | Australia | Savings vs USA |
|---|---|---|---|---|---|
| Dental Implant (single) | $800–$1,500 | $3,000–$6,000 | $2,500–$4,500 | $3,000–$5,500 | 70–80% |
| LASIK Eye Surgery (both eyes) | $1,500–$2,500 | $4,000–$5,000 | $2,800–$4,200 | $3,500–$5,000 | 60–75% |
| Executive Health Screening | $500–$900 | $2,500–$5,000 | $1,500–$3,000 | $2,000–$4,000 | 70–80% |
| Hip Replacement (total) | $8,000–$15,000 | $32,000–$44,000 | $15,000–$25,000 | $20,000–$35,000 | 65–75% |
| Knee Replacement (total) | $7,500–$14,000 | $30,000–$40,000 | $14,000–$22,000 | $18,000–$30,000 | 65–75% |
| Cataract Surgery (per eye) | $800–$1,500 | $3,500–$5,000 | $2,500–$4,000 | $2,500–$4,500 | 70–80% |
| Full Arch Dental Restoration | $6,000–$12,000 | $25,000–$45,000 | $18,000–$35,000 | $20,000–$40,000 | 70–80% |
Sources: OECD Health Statistics 2024; WHO Global Health Expenditure Database; International Federation of Health Plans 2023 Comparative Price Report; published pricing from Peking University International Hospital, Jishuitan Hospital, and Tongren Hospital.
By Procedure: Cost Breakdowns
Dental Implant Costs: China vs Western Countries
A single dental implant in China at a Grade 3A hospital costs between $800 and $1,500 USD, inclusive of the titanium implant, abutment, and ceramic crown. The same procedure in the United States ranges from $3,000 to $6,000 per tooth, according to the American Dental Association’s 2023 Cost Survey.
For patients requiring multiple implants or full-arch restoration, the savings compound significantly. A full-arch All-on-4 restoration in China costs $6,000–$12,000 compared to $25,000–$45,000 in the USA — a saving of $15,000–$33,000 on a single treatment episode.
SinoRX partners exclusively with Grade 3A dental hospitals using Straumann, Nobel Biocare, and Osstem implant systems — the same brands used in premium Western clinics.
LASIK Eye Surgery Costs: China vs Western Countries
LASIK bilateral correction (both eyes) at a Grade 3A ophthalmology centre in China costs $1,500–$2,500 USD. This includes pre-operative corneal mapping, the procedure itself using Alcon WaveLight or ZEISS MEL 90 platforms, and post-operative follow-up.
In the United States, bilateral LASIK ranges from $4,000 to $5,000 according to the American Refractive Surgery Council’s 2024 pricing data. UK private clinics charge £2,200–£3,400 (approximately $2,800–$4,200 USD).
LASIK outcomes at China’s top ophthalmology centres are statistically equivalent to Western benchmarks for both visual acuity gain and complication rate, with Beijing Tongren Hospital — ranked #1 in China for ophthalmology — performing over 10,000 refractive procedures annually using current-generation laser platforms.
Hip and Knee Replacement: China vs Western Countries
A total hip replacement at a Grade 3A orthopedic centre in China costs $8,000–$15,000 USD, and a total knee replacement $7,500–$14,000 USD. The same procedures in the US range $30,000–$44,000, in the UK private system £12,000–£20,000 ($15,000–$25,000 USD), and in Australia AU$28,000–$50,000 ($20,000–$35,000 USD).
Jishuitan Hospital in Beijing — ranked #1 in China for orthopedics by the Fudan University Hospital Rankings — performs over 30,000 orthopedic surgeries annually using FDA-approved Zimmer Biomet, Stryker, and DePuy Synthes implants. Most patients walk within 24 hours of surgery and fly home within 2–3 weeks.
Cataract Surgery: China vs Western Countries
Cataract surgery per eye at a Grade 3A ophthalmology centre in China costs $800–$1,500 USD, inclusive of phacoemulsification, monofocal IOL implantation, and follow-up. US private rates range $3,500–$5,000 per eye; UK private clinics charge £2,000–£3,200 ($2,500–$4,000 USD); Australian private surgery is AU$3,500–$6,500 per eye ($2,500–$4,500 USD).
Premium IOL upgrades (toric, multifocal, extended depth of focus) typically add $400–$1,200 per eye in China and remain well below comparable Western premiums.
Executive Health Screening: China vs Western Countries
A same-day executive health screening at Peking University International Hospital costs $500–$900 USD and includes 60+ blood markers, CT or MRI imaging, cardiac assessment, cancer marker panel, and a specialist consultation. Comparable executive screenings in the US run $2,500–$5,000; UK private programmes range £1,200–£2,400 ($1,500–$3,000 USD); Australian executive packages are AU$2,800–$5,500 ($2,000–$4,000 USD).
Methodology & Sources
China prices reflect published rate-card pricing at Grade 3A partner hospitals in Beijing and Shanghai. Implants and consumables (Zimmer Biomet, Stryker, DePuy Synthes, Straumann, Nobel Biocare, Carl Zeiss, Alcon) are included in the procedure price unless otherwise noted.
Western prices are median market rates triangulated across three sources: government health statistics (OECD, NHS England, Medicare price files), insurer-published comparative reports (International Federation of Health Plans 2023), and specialty-association cost surveys (American Dental Association, American Refractive Surgery Council).
Cited data sources:
- OECD Health Statistics 2024
- WHO Global Health Expenditure Database
- International Federation of Health Plans 2023 Comparative Price Report
- American Dental Association 2023 Cost Survey
- American Refractive Surgery Council 2024 pricing data
- Published pricing from Peking University International Hospital, Jishuitan Hospital, and Beijing Tongren Hospital
Prices change. SinoRX confirms a binding quote in writing before any treatment is booked.
Frequently Asked Questions
How much can I save by having dental implants in China?
A single dental implant at a Grade 3A hospital in China costs $800–$1,500, compared to $3,000–$6,000 in the United States. For full-arch restoration (All-on-4), China prices range $6,000–$12,000 versus $25,000–$45,000 in the US — a saving of $15,000–$33,000 on a single treatment episode.
Are Grade 3A hospitals in China safe for international patients?
Yes. Grade 3A is China’s highest national hospital classification, held by approximately 1,500 of 35,000+ hospitals. These institutions are audited against hundreds of indicators including clinical outcomes, staffing credentials, equipment standards, and patient safety systems. For most elective procedures, complication rates are comparable to leading Western institutions.
What sources back the price data on this page?
OECD Health Statistics 2024, the WHO Global Health Expenditure Database, the International Federation of Health Plans 2023 Comparative Price Report, and published pricing from Peking University International Hospital, Jishuitan Hospital, and Beijing Tongren Hospital.
What’s included in the China price ranges?
China prices reflect Grade 3A hospital rates at published rate-card pricing in Beijing or Shanghai, inclusive of the procedure, standard hospital stay, and initial follow-up. Implants and consumables (e.g., Straumann, Zimmer Biomet, Carl Zeiss) are included. Excluded: international airfare, hotel, and travel insurance.
How does SinoRX coordinate access to these prices?
SinoRX is a medical concierge that books your treatment at top-ranked Grade 3A hospitals across Beijing. We handle specialist matching, direct scheduling with department heads, bilingual coordination during consultations and surgery, and English-language discharge documentation. Hospital fees are paid directly to the hospital at published rates with no markup; SinoRX charges a separate, disclosed coordination fee.
Are there hidden costs beyond the procedure price?
International airfare ($800–$1,500 from most Western capitals), accommodation ($60–$200 per night), local transport, and travel insurance are not included in procedure pricing. For most patients these total $2,000–$4,000 — still leaving 50–70% total savings versus equivalent treatment at home.
How do I verify a hospital’s Grade 3A status?
China’s National Health Commission publishes the official hospital registry. SinoRX confirms the Grade 3A status of every partner hospital in writing before any treatment planning begins. Reclassifications are infrequent, and our major partner hospitals have held Grade 3A status for decades.